ExploreWatchlistsPricing
  1. US-listed companies
  2. Jaguar Health, Inc.
  3. Financials
  4. EBITDA

Jaguar Health, Inc. (JAGX)

Market cap
$25.39M
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Dec 31, 2025-44+52.07%
Dec 31, 2024-29-10.37%
Dec 31, 2023-32-0.48%
Dec 31, 2022-32-16.81%
Dec 31, 2021-39+56.46%
Dec 31, 2020-25-8.42%
Dec 31, 2019-27-7.77%
Dec 31, 2018-30-12.35%
Dec 31, 2017-34+148.64%
Dec 31, 2016-14+8.83%
Dec 31, 2015-12

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat